Treatment With Mycophenolate and Cyclophosphamide Leads to Clinically Meaningful Improvements in Patient‐Reported Outcomes in Scleroderma Lung Disease: Results of Scleroderma Lung Study II

OBJECTIVE: Our objective was to determine if treatment with cyclophosphamide (CYC) and mycophenolate mofetil (MMF) improves patient‐reported outcomes (PROs) among patients with systemic sclerosis‐related interstitial lung disease (SSc‐ILD). METHODS: This study examined PROs in patients with SSc‐ILD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:ACR Open Rheumatol
Main Authors: Volkmann, Elizabeth R., Tashkin, Donald P., LeClair, Holly, Roth, Michael D., Kim, Grace, Goldin, Jonathan, Clements, Philip J., Furst, Daniel E., Khanna, Dinesh
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7301868/
https://ncbi.nlm.nih.gov/pubmed/32432411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/acr2.11125
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados